Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05877053 · ClinicalTrials.gov registry record · Phase 1
A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants
A Phase 1 study, sponsored by Cytokinetics.
- Completed
- Registry status
- Phase 1
- Development phase
- 102
- Enrollment target
NCT05877053 is a Phase 1 study that has completed, run by Cytokinetics. The registered enrollment target is 102 participants.
The verdict
NCT05877053, a Phase 1 study, has completed, sponsored by Cytokinetics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 102 participants
- Enrollment target
Study Summary
The purposes of this study are to: * Learn about the safety and tolerability of CK 4021586 after a single dose and multiple doses in healthy subjects. * Find out how much CK-4021586 is in the blood after a single dose and multiple doses. * Determine the effect different doses of CK-4021586 on the pumping function of the heart. * Determine the effect of food in the stomach on how much CK-4021586 is in the blood after a single dose.
Interventions
- DRUG CK-4021586
- DRUG Placebo for CK-4021586
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2023-05-09 |
| Est. Completion | 2024-11-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05877053
The ClinicalTrials.gov registry entry for NCT05877053 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cytokinetics, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CK-4021586 is the first listed.
NCT05877053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05877053 about?
NCT05877053 is a clinical study titled "A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants". The purposes of this study are to: * Learn about the safety and tolerability of CK 4021586 after a single dose and multiple doses in healthy subjects. * Find out how much CK-4021586 is in the blood after a single dose and multiple doses. * Determine the effect different doses of CK-4021586 on the p...
What is the current status of trial NCT05877053?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 102 participants. The study started on 2023-05-09. Estimated completion is 2024-11-20.
What interventions are being tested in trial NCT05877053?
The interventions under investigation include: CK-4021586 (DRUG), Placebo for CK-4021586 (DRUG).
Who is sponsoring clinical trial NCT05877053?
This trial is sponsored by Cytokinetics, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.